1. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
The Association Between Primary Tumor Location and Survival in Colorectal Cancer
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

2. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Study Motivation
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

3. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Study Objective
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

4. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Study Data Sources: <br />18 Tumor Registries in NCI‘s SEER Program since 2000<br />Linkage to Medicare Enrollment and Claims Data
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

5. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Study Methods
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

6. Categorization of Colorectal Primary Sites<br />
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

7. Tumor Location and Age, Stage At Diagnosis
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

8. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage IV Colorectal Cancer <br />by Primary Tumor Location and Year of Diagnosis<br />
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

9. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival for Stage IV CRC from SEER <br />by Tumor Location, Diagnoses
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

10. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival for Stage IV CRC in SEER<br />by Primary Tumor Location, Diagnoses
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

11. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival for Stage IV CRC <br />by Primary Tumor Location and Year of Diagnosis<br />
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

12. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
<br />Stage IV CRC Median Survival in Months<br />by Primary Tumor Location and Year of Diagnosis
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

13. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival in Stage III CRC <br />by Primary Tumor Location,
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

14. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival for Stage III CRC <br />by Primary Tumor Location and Year of Diagnosis
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

15. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage III CRC Median Survival in Months<br />by Primary Tumor Location and Year of Diagnosis
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

16. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival in Stage II CRC <br />by Primary Tumor Location,
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

17. Is the Association Between Sidedness and Prognosis All Lead Time?
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

18. Stage III CRC By Primary Tumor Location and Substage
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

19. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Overall Survival for Stage III CRC <br />by tumor location and AJCC sub-stage
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

20. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
<br />Stage IV subgroup diagnosed enrolled in Medicare and treated with Cetuximab or panitumumab ascertained from Medicare claimss<br />
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

21. Stage IV: Survival from first dose of Cetuximab/P-mab
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

22. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Discussion: Relating Phenotype to Genotype<br />Consensus Molecular Subtypes in Colorectal Cancer
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

23. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Discussion: Relating Phenotype to Genotype<br />Consensus Molecular Subtypes
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

24. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Study Conclusions
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

25. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
THANK YOU!
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

26. Presented By Deborah Schrag at 2016 ASCO Annual Meeting
Stage III Colorectal Cancer <br />by Primary Tumor Location and Year of Diagnosis
Presented By Deborah Schrag at 2016 ASCO Annual Meeting

27. Stage IV CRC: <br />Adjusted Hazard Ratios for Overall Survival
Presented By Deborah Schrag at 2016 ASCO Annual Meeting